Laquinimod dampens IL-1β signaling and Th17-polarizing capacity of monocytes in patients with MS

Objective To assess the impact of laquinimod treatment on monocytes and to investigate the underlying immunomodulatory mechanisms in MS. - Methods In this cross-sectional study, we performed in vivo and in vitro analyses of cluster of differentiation (CD14+) monocytes isolated from healthy donors (n...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Engel, Sinah (VerfasserIn) , Jolivel, Valérie (VerfasserIn) , Kraus, Stefan H.-P. (VerfasserIn) , Zayoud, Morad (VerfasserIn) , Rosenfeld, Karolina (VerfasserIn) , Tumani, Hayrettin (VerfasserIn) , Furlan, Roberto (VerfasserIn) , Kurschus, Florian (VerfasserIn) , Waisman, Ari (VerfasserIn) , Luessi, Felix (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2021
In: Neurology: Neuroimmunology & Neuroinflammation ; official journal of the American Academy of Neurology
Year: 2020, Jahrgang: 8, Heft: 1, Pages: 1-10
ISSN:2332-7812
DOI:10.1212/NXI.0000000000000908
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1212/NXI.0000000000000908
Verlag, lizenzpflichtig, Volltext: https://nn.neurology.org/content/8/1/e908
Volltext
Verfasserangaben:Sinah Engel, MD, Valérie Jolivel, PhD, Stefan H.-P. Kraus, PhD, Morad Zayoud, MD, Karolina Rosenfeld, Hayrettin Tumani, MD, Roberto Furlan, MD, PhD, Florian C. Kurschus, PhD, Ari Waisman, PhD, and Felix Luessi, MD

MARC

LEADER 00000caa a2200000 c 4500
001 1750097273
003 DE-627
005 20220819123036.0
007 cr uuu---uuuuu
008 210302r20212020xx |||||o 00| ||eng c
024 7 |a 10.1212/NXI.0000000000000908  |2 doi 
035 |a (DE-627)1750097273 
035 |a (DE-599)KXP1750097273 
035 |a (OCoLC)1341396579 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Engel, Sinah  |d 1990-  |e VerfasserIn  |0 (DE-588)1215642806  |0 (DE-627)172675121X  |4 aut 
245 1 0 |a Laquinimod dampens IL-1β signaling and Th17-polarizing capacity of monocytes in patients with MS  |c Sinah Engel, MD, Valérie Jolivel, PhD, Stefan H.-P. Kraus, PhD, Morad Zayoud, MD, Karolina Rosenfeld, Hayrettin Tumani, MD, Roberto Furlan, MD, PhD, Florian C. Kurschus, PhD, Ari Waisman, PhD, and Felix Luessi, MD 
246 3 3 |a Laquinimod dampens IL-one beta signaling and Th seventeen-polarizing capacity of monocytes in patients with MS 
264 1 |c 2021 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a First published November 17, 2020 
500 |a Gesehen am 02.03.2021 
520 |a Objective To assess the impact of laquinimod treatment on monocytes and to investigate the underlying immunomodulatory mechanisms in MS. - Methods In this cross-sectional study, we performed in vivo and in vitro analyses of cluster of differentiation (CD14+) monocytes isolated from healthy donors (n = 15), untreated (n = 13), and laquinimod-treated patients with MS (n = 14). Their frequency and the expression of surface activation markers were assessed by flow cytometry and the viability by calcein staining. Cytokine concentrations in the supernatants of lipopolysaccharide (LPS)-stimulated monocytes were determined by flow cytometry. The messenger ribonucleic acid (mRNA) expression level of genes involved in cytokine expression was measured by quantitative PCR. The LPS-mediated nuclear factor kappa-light-chain-enhancer of activated B-cell (NF-κB) activation was determined by the quantification of the phosphorylation level of the p65 subunit. Laquinimod-treated monocytes were cocultured with CD4+ T cells, and the resulting cytokine production was analyzed by flow cytometry after intracellular cytokine staining. The interleukin (IL)-17A concentration of the supernatant was assessed by ELISA. - Results Laquinimod did not alter the frequency or viability of circulating monocytes, but led to an upregulation of CD86 expression. LPS-stimulated monocytes of laquinimod-treated patients with MS secreted less IL-1β following a downregulation of IL-1β gene expression. Phosphorylation levels of the NF-κB p65 subunit were reduced after laquinimod treatment, indicating a laquinimod-associated inhibition of the NF-κB pathway. T cells primed with laquinimod-treated monocytes differentiated significantly less into IL-17A-producing T helper (Th)-17 cells. - Conclusions Our findings suggest that inhibited NF-κB signaling and downregulation of IL-1β expression in monocytes contributes to the immunomodulatory effects of laquinimod and that the impairment of Th17 polarization might mediate its disease-modifying activity in MS. 
534 |c 2020 
700 1 |a Jolivel, Valérie  |e VerfasserIn  |4 aut 
700 1 |a Kraus, Stefan H.-P.  |e VerfasserIn  |4 aut 
700 1 |a Zayoud, Morad  |e VerfasserIn  |4 aut 
700 1 |a Rosenfeld, Karolina  |e VerfasserIn  |4 aut 
700 1 |a Tumani, Hayrettin  |e VerfasserIn  |4 aut 
700 1 |a Furlan, Roberto  |e VerfasserIn  |4 aut 
700 1 |a Kurschus, Florian  |d 1969-  |e VerfasserIn  |0 (DE-588)122999916  |0 (DE-627)706122887  |0 (DE-576)29351464X  |4 aut 
700 1 |a Waisman, Ari  |e VerfasserIn  |4 aut 
700 1 |a Luessi, Felix  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Neurology: Neuroimmunology & Neuroinflammation ; official journal of the American Academy of Neurology  |d Philadelphia, Pa. : Wolters Kluwer, 2014  |g 8(2021,1) Artikel-Nummer e908, 10 Seiten  |h Online-Ressource  |w (DE-627)784191956  |w (DE-600)2767740-0  |w (DE-576)404866883  |x 2332-7812  |7 nnas  |a Laquinimod dampens IL-1β signaling and Th17-polarizing capacity of monocytes in patients with MS 
773 1 8 |g volume:8  |g year:2021  |g number:1  |g elocationid:e908  |g pages:1-10  |a Laquinimod dampens IL-1β signaling and Th17-polarizing capacity of monocytes in patients with MS 
856 4 0 |u https://doi.org/10.1212/NXI.0000000000000908  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://nn.neurology.org/content/8/1/e908  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210302 
993 |a Article 
994 |a 2021 
998 |g 122999916  |a Kurschus, Florian  |m 122999916:Kurschus, Florian  |d 910000  |d 911300  |e 910000PK122999916  |e 911300PK122999916  |k 0/910000/  |k 1/910000/911300/  |p 8 
999 |a KXP-PPN1750097273  |e 3879858055 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1212/NXI.0000000000000908"],"eki":["1750097273"]},"relHost":[{"pubHistory":["1.2014 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 28.04.14"],"id":{"zdb":["2767740-0"],"issn":["2332-7812"],"eki":["784191956"]},"part":{"text":"8(2021,1) Artikel-Nummer e908, 10 Seiten","volume":"8","year":"2021","issue":"1","pages":"1-10"},"physDesc":[{"extent":"Online-Ressource"}],"recId":"784191956","title":[{"title":"Neurology: Neuroimmunology & Neuroinflammation ; official journal of the American Academy of Neurology","title_sort":"Neurology: Neuroimmunology & Neuroinflammation ; official journal of the American Academy of Neurology"}],"disp":"Laquinimod dampens IL-1β signaling and Th17-polarizing capacity of monocytes in patients with MSNeurology: Neuroimmunology & Neuroinflammation ; official journal of the American Academy of Neurology","language":["eng"],"origin":[{"publisher":"Wolters Kluwer ; Lippincott Williams & Wilkins","publisherPlace":"Philadelphia, Pa. ; Philadelphia, Pa.","dateIssuedKey":"2014","dateIssuedDisp":"2014-"}]}],"name":{"displayForm":["Sinah Engel, MD, Valérie Jolivel, PhD, Stefan H.-P. Kraus, PhD, Morad Zayoud, MD, Karolina Rosenfeld, Hayrettin Tumani, MD, Roberto Furlan, MD, PhD, Florian C. Kurschus, PhD, Ari Waisman, PhD, and Felix Luessi, MD"]},"title":[{"title":"Laquinimod dampens IL-1β signaling and Th17-polarizing capacity of monocytes in patients with MS","title_sort":"Laquinimod dampens IL-1β signaling and Th17-polarizing capacity of monocytes in patients with MS"}],"recId":"1750097273","titleAlt":[{"title":"Laquinimod dampens IL-one beta signaling and Th seventeen-polarizing capacity of monocytes in patients with MS"}],"language":["eng"],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"2021"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"given":"Sinah","display":"Engel, Sinah","family":"Engel","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Jolivel, Valérie","given":"Valérie","role":"aut","roleDisplay":"VerfasserIn","family":"Jolivel"},{"family":"Kraus","roleDisplay":"VerfasserIn","role":"aut","given":"Stefan H.-P.","display":"Kraus, Stefan H.-P."},{"role":"aut","roleDisplay":"VerfasserIn","family":"Zayoud","display":"Zayoud, Morad","given":"Morad"},{"roleDisplay":"VerfasserIn","family":"Rosenfeld","role":"aut","given":"Karolina","display":"Rosenfeld, Karolina"},{"role":"aut","family":"Tumani","roleDisplay":"VerfasserIn","display":"Tumani, Hayrettin","given":"Hayrettin"},{"role":"aut","family":"Furlan","roleDisplay":"VerfasserIn","display":"Furlan, Roberto","given":"Roberto"},{"role":"aut","family":"Kurschus","roleDisplay":"VerfasserIn","display":"Kurschus, Florian","given":"Florian"},{"role":"aut","roleDisplay":"VerfasserIn","family":"Waisman","display":"Waisman, Ari","given":"Ari"},{"role":"aut","roleDisplay":"VerfasserIn","family":"Luessi","display":"Luessi, Felix","given":"Felix"}],"note":["First published November 17, 2020","Gesehen am 02.03.2021"]} 
SRT |a ENGELSINAHLAQUINIMOD2021